Shares of Tilray Brands, Inc. (NASDAQ:TLRY - Get Free Report) have been given an average recommendation of "Hold" by the five research firms that are presently covering the company, Marketbeat reports. Four investment analysts have rated the stock with a hold recommendation and one has assigned a buy recommendation to the company. The average 12 month target price among brokers that have updated their coverage on the stock in the last year is $1.92.
Several equities research analysts have recently issued reports on TLRY shares. Roth Capital reiterated a "neutral" rating on shares of Tilray Brands in a report on Monday, April 14th. Zelman & Associates reiterated a "neutral" rating on shares of Tilray Brands in a report on Tuesday. Wall Street Zen lowered Tilray Brands to a "strong sell" rating in a report on Saturday, July 5th. Finally, Piper Sandler reduced their target price on Tilray Brands from $2.00 to $1.00 and set a "neutral" rating for the company in a report on Wednesday, April 9th.
Get Our Latest Analysis on TLRY
Institutional Inflows and Outflows
Large investors have recently modified their holdings of the company. Tidal Investments LLC grew its position in Tilray Brands by 9.2% in the fourth quarter. Tidal Investments LLC now owns 10,595,264 shares of the company's stock valued at $14,092,000 after acquiring an additional 889,086 shares during the period. Bank of Montreal Can lifted its stake in shares of Tilray Brands by 14.4% during the fourth quarter. Bank of Montreal Can now owns 2,488,982 shares of the company's stock valued at $3,310,000 after acquiring an additional 312,476 shares during the period. Geode Capital Management LLC lifted its stake in shares of Tilray Brands by 20.1% during the fourth quarter. Geode Capital Management LLC now owns 2,405,911 shares of the company's stock valued at $3,200,000 after acquiring an additional 403,371 shares during the period. Dimensional Fund Advisors LP lifted its stake in shares of Tilray Brands by 54.8% during the fourth quarter. Dimensional Fund Advisors LP now owns 2,172,935 shares of the company's stock valued at $2,890,000 after acquiring an additional 769,569 shares during the period. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its stake in shares of Tilray Brands by 17.1% during the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,964,380 shares of the company's stock valued at $2,613,000 after acquiring an additional 286,481 shares during the period. 9.35% of the stock is currently owned by institutional investors and hedge funds.
Tilray Brands Price Performance
NASDAQ:TLRY opened at $0.70 on Tuesday. The business's 50-day moving average price is $0.49 and its 200 day moving average price is $0.64. The firm has a market cap of $704.25 million, a P/E ratio of -0.67 and a beta of 1.82. Tilray Brands has a 52-week low of $0.35 and a 52-week high of $2.15. The company has a quick ratio of 1.61, a current ratio of 2.62 and a debt-to-equity ratio of 0.12.
Tilray Brands (NASDAQ:TLRY - Get Free Report) last issued its quarterly earnings results on Monday, July 28th. The company reported $0.02 earnings per share for the quarter, topping analysts' consensus estimates of ($0.03) by $0.05. Tilray Brands had a negative return on equity of 7.40% and a negative net margin of 113.85%. The firm had revenue of $224.54 million for the quarter, compared to analysts' expectations of $250.41 million. As a group, sell-side analysts predict that Tilray Brands will post -0.2 earnings per share for the current fiscal year.
Tilray Brands Company Profile
(
Get Free ReportTilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Tilray Brands, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tilray Brands wasn't on the list.
While Tilray Brands currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.